TR200102009T2 - Serebral işlemi profilaksı ve tedavisi için formül I'e göre bileşiklerin kullanımı - Google Patents

Serebral işlemi profilaksı ve tedavisi için formül I'e göre bileşiklerin kullanımı

Info

Publication number
TR200102009T2
TR200102009T2 TR2001/02009T TR200102009T TR200102009T2 TR 200102009 T2 TR200102009 T2 TR 200102009T2 TR 2001/02009 T TR2001/02009 T TR 2001/02009T TR 200102009 T TR200102009 T TR 200102009T TR 200102009 T2 TR200102009 T2 TR 200102009T2
Authority
TR
Turkey
Prior art keywords
formula
cerebral
treatment
prophylaxis
compounds according
Prior art date
Application number
TR2001/02009T
Other languages
English (en)
Turkish (tr)
Inventor
Steiner Gerd
Schellhaas Kurt
Lubisch Wilfried
Holzenkamp Uta
Starck Dorothea
Szabo Laszlo
Emling Franz
Javier Garcia-Ladona Francisco
Hofmann Hans-Peter
Unger Liliane
Original Assignee
Basf Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag. filed Critical Basf Ag.
Publication of TR200102009T2 publication Critical patent/TR200102009T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
TR2001/02009T 1999-01-11 1999-12-22 Serebral işlemi profilaksı ve tedavisi için formül I'e göre bileşiklerin kullanımı TR200102009T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19900544A DE19900544A1 (de) 1999-01-11 1999-01-11 Verwendung von Verbindungen der Formel I zur Prophylaxe und Therapie der zerebralen Ischämie

Publications (1)

Publication Number Publication Date
TR200102009T2 true TR200102009T2 (tr) 2002-01-21

Family

ID=7893835

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/02009T TR200102009T2 (tr) 1999-01-11 1999-12-22 Serebral işlemi profilaksı ve tedavisi için formül I'e göre bileşiklerin kullanımı

Country Status (19)

Country Link
EP (1) EP1140099A1 (de)
JP (1) JP2002534467A (de)
KR (1) KR20010101440A (de)
CN (1) CN1333685A (de)
AR (1) AR029741A1 (de)
AU (1) AU2285100A (de)
BG (1) BG105688A (de)
BR (1) BR9916888A (de)
CA (1) CA2359390A1 (de)
DE (1) DE19900544A1 (de)
HU (1) HUP0200520A3 (de)
IL (1) IL144145A0 (de)
MX (1) MXPA01006966A (de)
NO (1) NO20013408L (de)
PL (1) PL348916A1 (de)
SK (1) SK9682001A3 (de)
TR (1) TR200102009T2 (de)
WO (1) WO2000041697A1 (de)
ZA (1) ZA200105473B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4654035B2 (ja) 2002-11-05 2011-03-16 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー 抗菌剤
CA2539479C (en) * 2003-09-23 2010-07-06 Merck & Co., Inc. Isoquinoline potassium channel inhibitors
CN101296914B (zh) * 2005-08-26 2012-07-18 盐野义制药株式会社 具有ppar激动活性的衍生物
AU2008301884B2 (en) * 2007-09-20 2012-12-20 Cortex Pharmaceuticals, Inc. 3-substituted 1,2,3-triazin-4-one's and 3-substituted 1,3-pyrimidinone's for enhancing glutamatergic synaptic responses
MA41168A (fr) 2014-12-17 2017-10-24 Acraf Nouveaux composés antibactériens
CN108484594B (zh) * 2018-02-09 2020-08-04 福建医科大学 一种烷氧基取代四氢吡啶并嘧啶类化合物或其可用盐及其制备方法与应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3620643A1 (de) * 1985-06-22 1987-01-22 Sandoz Ag Thiazole, ihre herstellung und verwendung
DE3831888A1 (de) * 1988-09-20 1990-03-29 Troponwerke Gmbh & Co Kg Arzneimittel zur behandlung von apoplexia cerebri
JP3036789B2 (ja) * 1990-06-22 2000-04-24 三井化学株式会社 新規な複素環式化合物及び医薬組成物
DE19746612A1 (de) * 1997-10-22 1999-04-29 Basf Ag 2-Substituierte 1,2-Benzisothiazol-Derivate, ihre Herstellung und Verwendung
DE19747063A1 (de) * 1997-10-24 1999-04-29 Basf Ag 3-substituierte Tetrahydropyridopyrimidinon-Derivate, ihre Herstellung und Verwendung

Also Published As

Publication number Publication date
CA2359390A1 (en) 2000-07-20
IL144145A0 (en) 2002-05-23
NO20013408D0 (no) 2001-07-10
PL348916A1 (en) 2002-06-17
EP1140099A1 (de) 2001-10-10
DE19900544A1 (de) 2000-07-13
WO2000041697A1 (de) 2000-07-20
ZA200105473B (en) 2002-10-03
HUP0200520A2 (hu) 2002-07-29
MXPA01006966A (es) 2002-04-10
NO20013408L (no) 2001-08-21
BR9916888A (pt) 2001-11-20
CN1333685A (zh) 2002-01-30
KR20010101440A (ko) 2001-11-14
AU2285100A (en) 2000-08-01
BG105688A (en) 2002-02-28
SK9682001A3 (en) 2002-03-05
AR029741A1 (es) 2003-07-16
JP2002534467A (ja) 2002-10-15
HUP0200520A3 (en) 2003-04-28

Similar Documents

Publication Publication Date Title
GB0005251D0 (en) Therapeutic compounds
TW200518753A (en) Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents
TNSN06032A1 (en) Pyridazine derivatives and their use as therapeutic agents
GB0225475D0 (en) Therapeutic agents
GB0225474D0 (en) Therapeutic agents
MY135841A (en) Novel benzodioxoles
GB0223038D0 (en) Therapeutic compounds
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
GB0025173D0 (en) Therapeutic agents
ATE248837T1 (de) Chinuclidin-acrylamide
ATE375341T1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
AU2002225772A1 (en) Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
BR0109703A (pt) Derivados de piperazina
MXPA04012965A (es) Inhibidores virales.
BG101118A (en) Therapeutical compounds
ATE402176T1 (de) Pyrrolidin- und azetidinverbindungen alsccr5- antagonisten
IL119207A0 (en) Treatment of tinnitus using neuroprotective agents
AP2002002664A0 (en) Cyclohexylamine derivative as subtype selective NMDA receptor antagonists.
TR199802060T2 (xx) Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�.
SE9802208D0 (sv) Novel compounds
BR9503572A (pt) Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença
TR200102008T2 (tr) Serebral işemi profilaksı ve tedavisi için piridin türevlerinin kullanımı.
DE60026491D1 (de) Melagatran zur behandlung von entzündungen
ATE360428T1 (de) Analgetisches arzneimittel
TR200102009T2 (tr) Serebral işlemi profilaksı ve tedavisi için formül I'e göre bileşiklerin kullanımı